12 Dec 2019
NEW YORK CVS Health Corp said on Thursday it will make it easier for patients with advanced cancer enrolled in some Aetna insurance plans to receive broad genetic gene sequencing tests that can help identify the best drug or treatment for them.
12 Dec 2019
NEW YORK, Dec 12 CVS Health Corp said on
Thursday it will make it easier for patients with advanced
cancer enrolled in some Aetna insurance plans to receive broad
genetic gene sequencing tests that can help identify the best
drug or treatment for them.
07 Nov 2019
CVS Health Corp reported higher-than-expected third-quarter profit on Wednesday as medical costs in its Aetna health insurance business came in below forecasts, and the company said its new strategy of using in-pharmacy clinics would contain healthcare spending going forward.
07 Nov 2019
Nov 6 CVS Health Corp reported
higher-than-expected third-quarter profit on Wednesday as
medical costs in its Aetna health insurance business came in
below forecasts, and the company said its new strategy of using
in-pharmacy clinics would contain healthcare spending going
forward.
23 Oct 2019
Anthem Inc on Wednesday signaled earnings for 2020 could be better than feared, allaying some concerns that rising medical costs are eating into profits and sending shares of the No. 2 health insurer up 4%.
23 Oct 2019
Oct 23 Anthem Inc on Wednesday signaled
earnings for 2020 could be better than feared, allaying some
concerns that rising medical costs are eating into profits and
sending shares of the No. 2 health insurer up 4%.
15 Oct 2019
UnitedHealth Group Inc on Tuesday provided an optimistic outlook for 2020 profit, saying it expected growth to be at least 13%, which outpaces current Wall Street estimates and sent its shares up as much as 8.6%.
15 Oct 2019
Oct 15 UnitedHealth Group Inc on Tuesday
provided an optimistic outlook for 2020 profit, saying it
expected growth to be at least 13%, which outpaces current Wall
Street estimates and sent its shares up as much as 8.6%.
08 Oct 2019
NEW YORK AbbVie Inc's rheumatoid arthritis drug Humira and Roche Holding AG's cancer drug Rituxan topped a list of seven treatments whose combined 2017 and 2018 price hikes accounted for a $5.1 billion increase in U.S. spending, a report released on Tuesday showed.
08 Oct 2019
NEW YORK, Oct 8 AbbVie Inc's arthritis
drug Humira and Roche Holding AG's cancer drug Rituxan
topped a list of seven treatments whose combined 2017 and 2018
price hikes accounted for a $5.1 billion increase in U.S.
spending, a report released on Tuesday showed.